JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
2726
DELISTED
Acceleron Pharma
XLRN
| $4.04M | ﹤0.01% |
95,299
+3,399
| +4% | +$127K |
|
|
BAS
2727
DELISTED
Basis Energy Services, Inc.
BAS
| $4.04M | ﹤0.01% |
172,145
+133,545
| +346% | +$2.78M |
|
2728
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $4.04M | ﹤0.01% |
48,142
+3,294
| +7% | +$278K |
|
|
NSH
2729
DELISTED
NuStar GP Holdings LLC
NSH
| $4.03M | ﹤0.01% |
256,636
+91,977
| +56% | +$1.53M |
|
|
SAND
2730
DELISTED
Sandstorm Gold
SAND
| $4.03M | ﹤0.01% |
806,778
+243,924
| +43% | +$1.11M |
|
2731
Mueller Water Products
MWA
$3.98B
| $4.01M | ﹤0.01% |
319,833
+113,605
| +55% | +$1.4M |
|
|
INVX
2732
Innovex International
INVX
$2.15B
| $4M | ﹤0.01% |
83,974
-619,409
| -88% | -$27.7M |
|
2733
PUT
NextEra Energy
NEE
$179B
| $4M | ﹤0.01% |
102,400
+34,400
| +51% | +$1.33M |
|
|
SCG
2734
PUT
DELISTED
Scana
SCG
| $4M | ﹤0.01% |
+100,500
| New | +$4.49M |
|
2735
PUT
eBay
EBAY
$46.5B
| $3.98M | ﹤0.01% |
105,400
-237,900
| -69% | -$8.83M |
|
2736
Minerva Neurosciences
NERV
$187M
| $3.98M | ﹤0.01% |
82,179
+33,641
| +69% | +$1.67M |
|
2737
Wabtec
WAB
$50.3B
| $3.98M | ﹤0.01% |
48,846
-490,505
| -91% | -$37.5M |
|
|
DCPH
2738
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.97M | ﹤0.01% |
+175,181
| New | +$3.43M |
|
|
TTM.RT
2739
CALL
DELISTED
TATA MOTORS LIMITED RT PUR ADR
TTM.RT
| $3.97M | ﹤0.01% |
+120,000
| New | +$3.97M |
|
2740
FIVE9
FIVN
$2.53B
| $3.97M | ﹤0.01% |
159,412
+8,409
| +6% | +$207K |
|
|
BFIN
2741
DELISTED
BankFinancial
BFIN
| $3.96M | ﹤0.01% |
258,236
+42,810
| +20% | +$684K |
|
2742
CALL
Mohawk Industries
MHK
$9.42B
| $3.94M | ﹤0.01% |
+14,300
| New | +$3.84M |
|
2743
PUT
Steris
STE
$23B
| $3.94M | ﹤0.01% |
+45,000
| New | +$4.01M |
|
2744
CALL
Itaú Unibanco
ITUB
$80.9B
| $3.92M | ﹤0.01% |
+622,365
| New | +$3.97M |
|
|
GMS
2745
DELISTED
GMS Inc
GMS
| $3.92M | ﹤0.01% |
104,123
-112,966
| -52% | -$4.03M |
|
2746
Alamos Gold
AGI
$13.8B
| $3.91M | ﹤0.01% |
600,576
-251,899
| -30% | -$1.64M |
|
2747
Prothena Corp
PRTA
$466M
| $3.91M | ﹤0.01% |
104,285
+5,085
| +5% | +$259K |
|
2748
Triumph Financial Inc
TFIN
$1.87B
| $3.91M | ﹤0.01% |
124,018
+16,148
| +15% | +$510K |
|
|
IXYS
2749
DELISTED
IXYS Corp
IXYS
| $3.9M | ﹤0.01% |
162,966
+80,579
| +98% | +$1.94M |
|
2750
Gogo Inc
GOGO
$377M
| $3.89M | ﹤0.01% |
345,083
+170,042
| +97% | +$1.81M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.